Incyte (INCY) Stock Forecast for 2023 – 2026. Sell or Buy Prediction

Incyte (INCY) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: December 3, 2023 (06:06)

Sector: Healthcare

The share price of Incyte Corp. (INCY) now

What analysts predict: $74.41
52-week High/Low: $86.29 / $50.27

50/200 Day Moving Average: $56.13 / $64.89

This figure corresponds to the Average Price over the previous 50/200 days. For Incyte stocks, the 50-day moving average is the resistance level today.

For Incyte stocks, the 200-day moving average is the resistance level today.

Are you interested in Incyte Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Incyte stock price in 2023, 2024, 2025, 2026, 2027. How much will one Incyte share be worth in 2023 - 2027?

When should I take profit in Incyte stock? When should I record a loss on Incyte stock? What are analysts' forecasts for Incyte stock? What is the future of Incyte stock? We forecast Incyte stock performance using neural networks based on historical data on Incyte stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Incyte stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Incyte shares. This happens once a day.




Historical and forecast chart of Incyte stock

The chart below shows the historical price of Incyte stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Incyte stock price can be found in the table below.

Long-term forecasts by years.

Incyte Corp is an American pharmaceutical company. The company was founded in Palo Alto, California in 1991 and became famous in 1993. Incyte has one drug, Jakafi, which has been approved by the US Food and Drug Administration (FDA) and has been prescribed to patients in the United States.

www.incyte.com

Incyte daily forecast for a month

Date Target Pes. Opt. Vol., %
Dec 05 54.16 53.22 55.41 4.12
Dec 06 53.91 52.90 54.74 3.49
Dec 07 52.94 52.56 54.18 3.08
Dec 08 51.80 50.63 53.04 4.76
Dec 09 52.20 51.59 53.43 3.55
Dec 10 52.41 52.03 52.72 1.33
Dec 11 51.76 50.65 52.07 2.82
Dec 12 51.39 50.48 51.75 2.50
Dec 13 52.82 51.95 53.98 3.90
Dec 14 53.38 52.71 54.48 3.37
Dec 15 52.03 51.28 52.94 3.23
Dec 16 52.38 51.25 53.23 3.86
Dec 17 53.21 52.84 53.58 1.39
Dec 18 54.63 53.45 55.06 3.00
Dec 19 54.57 53.62 55.53 3.57
Dec 20 54.99 54.18 56.15 3.62
Dec 21 54.27 53.74 54.79 1.94
Dec 22 55.37 54.72 56.57 3.37
Dec 23 55.39 54.44 56.52 3.82
Dec 24 54.52 53.22 55.11 3.57
Dec 25 54.15 53.27 55.20 3.63
Dec 26 54.28 53.51 55.04 2.86
Dec 27 53.51 52.87 54.65 3.37
Dec 28 54.19 53.47 55.49 3.77
Dec 29 55.24 54.30 56.52 4.09
Dec 30 55.69 54.96 56.19 2.25
Dec 31 55.54 54.56 56.16 2.93
Jan 01 55.14 54.38 56.05 3.07
Jan 02 55.03 53.95 56.00 3.79
Jan 03 55.11 54.48 56.31 3.37

Incyte Daily Price Targets


Incyte Stock Forecast 12-05-2023.

Forecast target price for 12-05-2023: $54.16.
Positive dynamics for Incyte shares will prevail with possible volatility of 3.959%.
Pessimistic target level: 53.22
Optimistic target level: 55.41

Incyte Stock Forecast 12-06-2023.

Forecast target price for 12-06-2023: $53.91.
Negative dynamics for Incyte shares will prevail with possible volatility of 3.369%.
Pessimistic target level: 52.90
Optimistic target level: 54.74

Incyte Stock Forecast 12-07-2023.

Forecast target price for 12-07-2023: $52.94.
Negative dynamics for Incyte shares will prevail with possible volatility of 2.990%.
Pessimistic target level: 52.56
Optimistic target level: 54.18

Incyte Stock Forecast 12-08-2023.

Forecast target price for 12-08-2023: $51.80.
Negative dynamics for Incyte shares will prevail with possible volatility of 4.541%.
Pessimistic target level: 50.63
Optimistic target level: 53.04

Incyte Stock Forecast 12-09-2023.

Forecast target price for 12-09-2023: $52.20.
Positive dynamics for Incyte shares will prevail with possible volatility of 3.430%.
Pessimistic target level: 51.59
Optimistic target level: 53.43

Incyte Stock Forecast 12-10-2023.

Forecast target price for 12-10-2023: $52.41.
Positive dynamics for Incyte shares will prevail with possible volatility of 1.312%.
Pessimistic target level: 52.03
Optimistic target level: 52.72

INCY (INCY) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Dec. 55.48 53.88 56.98 5.43

Incyte forecast for this year


Incyte Stock Prediction for Dec 2023

An uptrend is forecast for this month with an optimal target price of $55.4812. Pessimistic: $53.88. Optimistic: $56.98



Incyte (INCY) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 59.73 58.17 60.85 4.42
Feb 61.18 57.49 64.70 11.15
Mar 57.54 54.07 59.20 8.66
Apr 54.54 53.56 58.22 8.01
May 55.42 53.18 58.62 9.28
Jun 58.07 55.77 60.68 8.10
Jul 57.70 54.07 60.04 9.95
Aug 59.62 55.70 63.06 11.66
Sep 57.42 54.22 61.25 11.48
Oct 54.22 50.36 55.68 9.55
Nov 49.83 47.99 51.04 5.97
Dec 49.38 46.49 52.13 10.83

Incyte (INCY) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 48.84 47.61 50.65 5.99
Feb 46.73 45.81 48.16 4.89
Mar 50.81 49.31 52.05 5.27
Apr 52.41 50.01 56.00 10.70
May 54.30 50.59 55.91 9.53
Jun 52.74 51.65 56.44 8.49
Jul 48.37 45.32 50.94 11.02
Aug 44.45 43.45 45.57 4.65
Sep 43.93 42.04 46.03 8.68
Oct 43.26 41.78 45.21 7.58
Nov 45.40 44.42 47.61 6.69
Dec 49.12 48.19 51.20 5.87

Incyte (INCY) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 50.76 48.11 54.00 10.91
Feb 50.25 48.40 52.70 8.15
Mar 45.96 43.14 46.99 8.19
Apr 47.65 44.69 50.57 11.62
May 49.71 47.52 51.28 7.33
Jun 51.28 49.02 52.52 6.68
Jul 51.37 50.08 54.79 8.61
Aug 55.44 53.29 58.33 8.64
Sep 58.38 55.18 59.70 7.57
Oct 63.01 58.64 65.56 10.55
Nov 65.78 61.52 69.40 11.35
Dec 68.21 63.30 71.40 11.35

Incyte (INCY) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 70.12 67.02 75.16 10.83
Feb 68.47 65.64 72.79 9.82
Mar 66.56 64.05 71.36 10.24
Apr 63.99 60.82 66.00 7.85
May 65.72 60.98 67.49 9.64
Jun 67.96 63.87 72.43 11.82
Jul 69.19 66.32 71.24 6.90
Aug 71.55 69.75 75.48 7.59
Sep 74.71 72.89 79.35 8.13
Oct 79.28 76.57 81.28 5.79
Nov 83.85 80.07 87.09 8.06
Dec 81.36 75.72 86.56 12.52

Incyte information and performance

Incyte Address

1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, US

Market Capitalization: 12 043 617 000 $

Market capitalization of the Incyte Corp. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of INCY shares in the company outstanding by the market price of one share.

EBITDA: 626 796 000 $

EBITDA of Incyte is earnings before interest, income tax and depreciation of assets.

PE Ratio: 28.59

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 0.466

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.0059

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 1.88

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 0.52
Quarterly Revenue Growth YOY: 0.116
Trailing PE: 28.59

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 14.95

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 3.896

Enterprise Value (EV) /Revenue

EV To EBITDA: 18.63

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 224109000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.